| Literature DB >> 20425425 |
Abstract
Hodgkin disease was the first defined lymphoid neoplasm. For many decades it was regarded as a disease separate from non-Hodgkin lymphoma. However, recent studies have shown that the dysplastic cells of Hodgkin lymphoma (HL) are monoclonal B cells. This finding raised again the question "Is HL just another B-cell lymphoma?" This article reviews the different aspects of HL and B-cell non-Hodgkin lymphoma (B-NHL), concluding that-despite the same cell of origin-fundamental differences exist in morphology, cellular composition, immunophenotype, activation or inhibition of transcription factors, epigenetics, and clinical behavior. These findings lead us to conclude that HL and B-NHLs should stay as two separate categories.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20425425 DOI: 10.1007/s11899-009-0018-1
Source DB: PubMed Journal: Curr Hematol Malig Rep ISSN: 1558-8211 Impact factor: 3.952